World's Best Scientists 2026 revealed!
Award Badge
Biology and Biochemistry
Germany
2026

D-Index & Metrics

Biology and Biochemistry

D-Index
109
Citations
42321
World Ranking
1008
National Ranking
68

Medicine

D-Index
109
Citations
42373
World Ranking
5800
National Ranking
325

Research.com Recognitions

  • 2026 - Research.com Biology and Biochemistry in Germany Leader Award
  • 2025 - Research.com Biology and Biochemistry in Germany Leader Award

Overview

Susanne Schnittger is affiliated with Ludwig-Maximilians-Universität München in Germany. Their research primarily spans the field of Medicine with a particular focus on Oncology, Clinical Psychology, Pulmonary and Respiratory Medicine, Surgery, and Otorhinolaryngology.

The scientist's principal areas of study and research topics include:

  • Cancer survivorship and care
  • Head and Neck Cancer Studies
  • Psychiatric care and mental health services
  • Childhood Cancer Survivors' Quality of Life
  • Palliative Care and End-of-Life Issues
  • Family Support in Illness
  • Thyroid Cancer Diagnosis and Treatment

Susanne Schnittger has contributed frequently to several academic publication venues. These include:

  • Der Onkologe
  • Die Onkologie
  • Supportive Care in Cancer
  • Archives of Gynecology and Obstetrics
  • PPmP - Psychotherapie · Psychosomatik · Medizinische Psychologie

Among their recent scholarly output are papers covering various aspects of quality of life and clinical oncology topics:

  • Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: A synthesis across 21 clinical trials involving nine different cancer types, 2023, European Journal of Cancer
  • Health-related quality of life issues, including symptoms, in patients with active COVID-19 or post COVID-19; a systematic literature review, 2021, Quality of Life Research
  • Patients with adenoid cystic carcinomas of the salivary glands treated with lenvatinib: Activity and quality of life, 2020, Cancer
  • European Head and Neck Society recommendations for head and neck cancer survivorship care, 2022, Oral Oncology
  • Quality of Life in Patients With Hypoparathyroidism After Treatment for Thyroid Cancer, 2020, The Journal of Clinical Endocrinology & Metabolism

The scientist collaborates regularly with several coauthors, including:

  • Kathy Taylor
  • Lena Maier
  • Deborah Engesser
  • Martin Eichler
  • Naomi Kiyota

Best Publications

  • Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease.

    Susanne Schnittger;Claudia Schoch;Martin Dugas;Wolfgang Kern

  • BRAF mutations in hairy-cell leukemia

    Enrico Tiacci;Vladimir Trifonov;Gianluca Schiavoni;Antony Holmes

  • Dominant-negative mutations of CEBPA , encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia

    Thomas Pabst;Beatrice U. Mueller;Pu Zhang;Hanna S. Radomska

  • Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype

    Susanne Schnittger;Claudia Schoch;Wolfgang Kern;Cristina Mecucci

  • Landscape Of Genetic Lesions In 944 Patients With Myelodysplastic Syndromes

    Yasunobu Nagata;Vera Grossmann;Yusuke Okuno;Ulrike Bacher

  • Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin

    Ramiro Garzon;Michela Garofalo;Maria Paola Martelli;Roger Briesewitz

  • Real-Time Quantitative Polymerase Chain Reaction Detection of Minimal Residual Disease by Standardized WT1 Assay to Enhance Risk Stratification in Acute Myeloid Leukemia: A European LeukemiaNet Study

    Daniel Cilloni;Aline Renneville;Fabienne Hermitte;Robert Kerrin Hills

  • Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia

    Raphaël Itzykson;Olivier Kosmider;Aline Renneville;Véronique Gelsi-Boyer

  • New insights to the MLL recombinome of acute leukemias

    C. Meyer;E. Kowarz;J. Hofmann;A. Renneville

  • KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival

    Susanne Schnittger;Tobias M. Kohl;Torsten Haferlach;Wolfgang Kern

  • Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML).

    B. Hanfstein;M. C. Müller;R. Hehlmann;P. Erben

  • Prognostic relevance of FLT3-TKD mutations in AML: the combination matters—an analysis of 3082 patients

    Ulrike Bacher;Claudia Haferlach;Wolfgang Kern;Torsten Haferlach

  • Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV H status and immunophenotyping

    C Haferlach;F Dicker;S Schnittger;W Kern

  • AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases

    Claudia Schoch;Susanne Schnittger;Mirjam Klaus;Wolfgang Kern

  • Minimal residual disease levels assessed by NPM1 mutation–specific RQ-PCR provide important prognostic information in AML

    Susanne Schnittger;Wolfgang Kern;Claudia Tschulik;Tamara Weiss

  • Recurrent SETBP1 mutations in atypical chronic myeloid leukemia

    Rocco Piazza;Simona Valletta;Nils Winkelmann;Sara Redaelli

  • Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases

    C Schoch;S Schnittger;S Bursch;D Gerstner

  • Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 72.8% of Chronic Myelomonocytic Leukemia by Detecting Frequent Alterations in TET2, CBL, RAS, and RUNX1

    Alexander Kohlmann;Vera Grossmann;Hans-Ulrich Klein;Sonja Schindela

  • The MLL recombinome of acute leukemias.

    C. Meyer;B. Schneider;S. Jakob;S. Strehl

  • IDH1 mutations are detected in 6.6% of 1414 AML patients and are associated with intermediate risk karyotype and unfavorable prognosis in adults younger than 60 years and unmutated NPM1 status

    Susanne Schnittger;Claudia Haferlach;Madlen Ulke;Tamara Alpermann

Frequent Co-Authors

Torsten Haferlach
Torsten Haferlach MLL Munich Leukemia Laboratory
Wolfgang Kern
Wolfgang Kern Munich Leukemia Laboratory (Germany)
Claudia Haferlach
Claudia Haferlach Ludwig-Maximilians-Universität München
Claudia Schoch
Claudia Schoch MLL Munich Leukemia Laboratory
Wolfgang Hiddemann
Wolfgang Hiddemann Ludwig-Maximilians-Universität München
Martin Dugas
Martin Dugas Heidelberg University
Andreas Hochhaus
Andreas Hochhaus Friedrich Schiller University Jena
Rüdiger Hehlmann
Rüdiger Hehlmann Heidelberg University
Nicholas C.P. Cross
Nicholas C.P. Cross University of Southampton
Stefan W. Krause
Stefan W. Krause University of Erlangen-Nuremberg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a future in Biology or Biochemistry, there are several online degree and certificate options to help you gain specialized skills or shift your career path. For those focused on nutrition and health, best dietetics masters programs can prepare you for advanced roles as a registered dietitian or nutritionist.

Interested in starting your healthcare career more quickly? There are multiple online medical assistant programs with financial aid available, providing flexible options to earn your qualification while keeping costs manageable.

If you’re already working as a medical assistant but want to advance, consider ma to lpn bridge programs online. Bridge programs allow you to build on your experience and move into more specialized nursing roles.

For those seeking a broader foundation in biological sciences, several online biology degree options—even accelerated programs—are available. This pathway can open doors to research, teaching, laboratory work, and more, all while studying flexibly from home.

Best Scientists Citing Susanne Schnittger

Trending Scientists